Confidence in Metabolite Identification Dictates the Applicability of Metabolomics to Regulatory Toxicology
Current opinion in toxicology(2019)
摘要
The strength of omics technologies in toxicology is their ability to identify pathways of toxicity. Although pathway discovery is not required for chemical risk assessment, it can generate molecular biomarkers that accelerate the use of molecular assays in regulatory toxicology. For metabolomics, this application is limited by the challenge of metabolite identification. Here, we construct a framework around the confidence in identification of metabolites and molecular pathways and map multiple toxicometabolomics studies to this framework. This reveals that few studies achieve the highest level of confidence defined by the Metabolomics Standards Initiative. However, we argue that the level of confidence required is dependent on the regulatory application. For some, such as chemical grouping, current practices can suffice, whereas other applications require a more rigorous approach to metabolite identification.
更多查看译文
关键词
Metabolite annotation,Mass spectrometry,NMR spectroscopy,Biomarker discovery,Molecular key event,Chemical risk assessment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要